Drug resistant mutations (DRM) identified in HAART-naïve newly diagnosed infected individuals in Banna, China.

Note: DRMs analyses were implemented based on HIVdb algorithm. Bold font indicated DRMs which were also included in CPR ver.6.0 (SDRM 2009). Italic font indicated DRMs not included in 2013 IAS-USA.
*L33F is polymorphic in 19 individuals infected with HIV-1 subtype CRF01_AE.
NRTI, nucleoside reverse transcriptase inhibitors; NNRTI, non-nucleoside reverse transcriptase inhibitors; PI, protease inhibitors; 3TC, lamivudine; FTC, emtricitabine; ABC, abacavir; AZT, zidovudine; D4T, stavudine; DDI, didanosine; EFV, efavirenz; NVP, nevirapine; NFV, nelfinavir; ATV, Atazanavir; LPV/r, lopinavir and ritonavir; IDV, indinavir; S, susceptible; H, high-level resistance; I, intermediate resistance; L, low-level resistance; and PL, potential low-level resistance.
Drug resistant mutations (DRM) identified in HAART-naïve newly diagnosed infected individuals in Banna, China.